|
| Exchange Disseminated Time | Glenmark Pharmaceuticals Ltd has announced the following results for the quarter & year ended March 31, 2015:
The Standalone Results are as follows:
The Audited results for the Quarter ended March 31, 2015
The Company has posted a net profit of Rs. 6704.30 million for the quarter ended March 31, 2015 as compared to Rs. 1516.68 million for the quarter ended March 31, 2014. Total Income has increased from Rs. 6872.56 million for the quarter ended March 31, 2014 to Rs. 31577.90 million for the quarter ended March 31, 2015.
The Audited results for the Year ended March 31, 2015
The Company has posted a net profit of Rs. 10075.25 million for the year ended March 31, 2015 as compared to Rs. 4338.24 million for the year ended March 31, 2014. Total Income has increased from Rs. 23680.38 million for the year ended March 31, 2014 to Rs. 51705.43 million for the year ended March 31, 2015.
The Consolidated Results are as follows:
The Audited Consolidated results for the Quarter ended March 31, 2015
The Group has posted a net profit after taxes, Minority interest and Share of Profit/(Loss) of Associates of Rs. 106.13 million for the quarter ended March 31, 2015 as compared to Rs. 430.66 million for the quarter ended March 31, 2014. Total Income has increased from Rs. 16914.86 million for the quarter ended March 31, 2014 to Rs. 17761.38 million for the quarter ended March 31, 2015.
The Audited Consolidated results for the Year ended March 31, 2015
The Group has posted a net profit after taxes, Minority interest and Share of Profit/(Loss) of Associates of Rs. 4753.10 million for the year ended March 31, 2015 as compared to Rs. 5422.75 million for the year ended March 31, 2014. Total Income has increased from Rs. 60166.81 million for the year ended March 31, 2014 to Rs. 66516.47 million for the year ended March 31, 2015. |
|
|